• Home
  • Top News
  • World
  • Economy
  • science
  • Technology
  • sport
  • entertainment
  • Contact Form
Sunday, August 7, 2022
  • Login
No Result
View All Result
NEWSLETTER
BOB FM
No Result
View All Result
BOB FM
No Result
View All Result
Home Economy

BioNTech goes from loss to profit of $3,915.3 million in the first half – O Journal Economico

by Ursula Curtis
August 9, 2021
in Economy
0
José Miguel Calheiros Bankinter
0
SHARES
25
VIEWS
Share on FacebookShare on Twitter

German biotechnology company BioNTech, which developed a covid-19 vaccine with Pfizer, posted a net profit of 3915.3 million euros as of June, recovering from a loss of 141.7 million euros a year earlier.
BioNTech today said its operating profit was 5860.6 million euros in the first half compared to a loss of 140.2 million euros in the same period in 2020.

And the value of sales rose to 7,356.9 million euros, 106 times what it was a year ago, when it reached 69.4 million euros, and this is due to the “rapid increase in the delivery of a vaccine against Covid-19 worldwide.”

“We and our partner, Pfizer, have passed the milestone of 1 billion doses of covid-19 vaccine shipped worldwide. We are very proud to have achieved this milestone in the presentation of the results,” said BioNTech CEO and Founder, Ugur Sahin, in presenting the results. Only six months.”

To combat the epidemic, Shaheen said, the vaccine supply has been increased to more than 100 countries and regions around the world and access to low- and middle-income countries has been facilitated.

BioNtech now expects the vaccine to be licensed in more regions and for more populations, and clinical trials are taking place in children aged six months to 11 years and in healthy pregnant women.

Meanwhile, BioNtech is working to develop treatments for cancer, having recently begun new clinical trials in two programs.

Ursula Curtis

“Writer. Analyst. Avid travel maven. Devoted twitter guru. Unapologetic pop culture expert. General zombie enthusiast.”

See also  The Portuguese government is following with "great interest and concern" the security deterioration
Ursula Curtis

Ursula Curtis

"Writer. Analyst. Avid travel maven. Devoted twitter guru. Unapologetic pop culture expert. General zombie enthusiast."

Next Post
The flu vaccine is still available to everyone in Pelotas |  public

The flu vaccine is still available to everyone in Pelotas | public

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Navigate

  • Home
  • Top News
  • World
  • Economy
  • science
  • Technology
  • sport
  • entertainment
  • Contact Form

Pages

  • About Us
  • Privacy Policy
  • DMCA
  • Editorial Policy
  • Contact Form
  • About Us
  • Privacy Policy
  • DMCA
  • Editorial Policy
  • Contact Form

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • About Us
  • Contact Form
  • DMCA
  • Editorial Policy
  • Privacy Policy

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In